Investment Thesis
Accendra Health is in acute financial distress with negative stockholders equity (-$464.8M), negative operating cash flow (-$170M), and negative free cash flow (-$211.6M), indicating the balance sheet is technically insolvent. Despite strong gross margins (83.8%), weak operating execution and inability to cover debt service (0.2x interest coverage) make this a financially unsustainable business model.
Strengths
- Strong gross margin of 83.8% indicates pricing power in medical distribution
- Cash balance of $336.9M provides near-term operational runway
- Operates in stable healthcare wholesale sector with recurring revenue characteristics
Risks
- Negative stockholders equity of -$464.8M indicates technical balance sheet insolvency
- Operating cash flow of -$170M with free cash flow of -$211.6M reveals unsustainable cash burn destroying equity value
- Interest coverage ratio of 0.2x means operating income cannot service $1.5B debt obligations
- Current ratio of 0.49x indicates severe liquidity stress and probable debt covenant violations
- Unprofitable operations (-$6.5M net income) with operating margin collapse to 2.7% despite high gross margins suggest structural operating problems
Key Metrics to Watch
- Operating cash flow trajectory and monthly burn rate
- Cash balance depletion timeline and covenant compliance status
- Operating expense reduction initiatives and path to operating profitability
- Debt restructuring negotiations or covenant amendment status
Financial Metrics
Revenue
627.8M
Net Income
-6.5M
EPS (Diluted)
$-0.08
Free Cash Flow
-211.6M
Total Assets
2.4B
Cash
336.9M
Profitability Ratios
Gross Margin
83.8%
Operating Margin
2.7%
Net Margin
-1.0%
ROE
N/A
ROA
-0.3%
FCF Margin
-33.7%
Balance Sheet & Liquidity
Current Ratio
0.49x
Quick Ratio
0.43x
Debt/Equity
N/A
Debt/Assets
119.2%
Interest Coverage
0.16x
Long-term Debt
1.5B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-13T07:38:18.878459 |
Data as of: 2026-03-31 |
Powered by Claude AI